| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,020 | 4,160 | 22:24 | |
| 3,980 | 4,200 | 22:00 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion Provides Pipeline Update | ||
| Mo | EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion Announces Leadership Transition in R&D | ||
| 09.02. | ExpreS2ion Biotech: Herausforderungen und Chancen im Biotech-Sektor | ||
| 06.02. | ExpreS2ion Biotech Holding AB: ExpreS2ion announces financial results for the fourth quarter of 2024 | Hørsholm, Denmark, 6 February 2025 - ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its fourth quarter and full-year financial results for 2024. The report is available as an attachment... ► Artikel lesen | |
| 09.01. | EXPRES2ION BIOTECH HOLDING AB: ExpreS2ion to Present in Upcoming Investor and Scientific Events |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Kezar Life Sciences, Inc. - 8-K, Current Report | ||
| 25.03. | Kezar Life Sciences, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| 25.03. | Kezar drops after Q4 results and mid-stage data for lead asset | ||
| 25.03. | Kezar Life Sciences Touts Positive Data From Mid-Stage Study For Chronic Liver Disease Drug Candidate | ||
| 25.03. | Kezar berichtet über positive AIH-Studienergebnisse und Finanzen für 2024 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Orgenesis Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | ||
| 06.03. | Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies | Strategic Acquisition Designed to Expand Access to Cost-Effective, Scalable Regenerative Medicine Treatments GERMANTOWN, MD / ACCESS Newswire / March 6, 2025 / Orgenesis Inc. (OTCQX:ORGS) ("Orgenesis"... ► Artikel lesen | |
| 06.03. | Orgenesis Inc. - 8-K, Current Report | ||
| 28.01. | Orgenesis Inc: Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings | Funding Aimed at Accelerating Rollout of Decentralized CGT Platform GERMANTOWN, MD / ACCESS Newswire / January 28, 2025 / Orgenesis Inc. (OTCQX:ORGS) ("Orgenesis" or the "Company"), a global biotech... ► Artikel lesen | |
| 28.01. | Orgenesis Inc. - 8-K, Current Report |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.12.24 | Standard Supply AS: Financial calendar | ||
| 15.11.24 | Standard Supply AS: STSU - THIRD QUARTER 2024 financial results | ||
| 30.10.24 | XFRA D6Z0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 30.10.24 | XFRA D6Z0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSTANDARD SUPPLY... ► Artikel lesen | |
| 30.10.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 30.10.2024 | The following instruments on XETRA do have their first trading 30.10.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 30.10.2024
Aktien
1 PLTRKPL00014 Trakcja S.A.
2 GB00BPVDXX64... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09:27 | STECON Surges 13% on "Homes for Thais" Project Initiative | ||
| 17.03. | Broker Expects Double Profit Growth for STECON with Data Center Contracts | ||
| 14.03. | STECON Jumps 5% after Signing THB16 Billion Data Center Contracts with Google | ||
| 14.03. | STECON Signs THB16 Billion Construction Contract for Google's Data Center | ||
| 04.03. | STECON Surges 16% as Analyst Anticipates Turnaround in 1Q25 |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | 1,800 | +1,69 % |
| KEZAR LIFE SCIENCES INC | 4,100 | +0,49 % |
| ORGENESIS INC | 0,352 | 0,00 % |
| STANDARD SUPPLY AS | 1,710 | 0,00 % |
| STECON GROUP PCL NVDR | 16,265 | 0,00 % |
